MFS Multi-Market Income Fund
Change company Symbol lookup
Select an option...
MMT MFS Multi-Market Income Fund
IMGN ImmunoGen Inc
BEN Franklin Resources Inc
BAC Bank of America Corp
EVH Evolent Health Inc
EEA The European Equity Fund Inc
BSTG Biostage Inc
UTX United Technologies Corp
USG USG Corp
USB U.S. Bancorp
Go

Company profile

MFS Multimarket Income Trust (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is to seek high current income, but may also consider capital appreciation. The Fund's investment portfolio includes High Yield Corporates, Investment Grade Corporates, Emerging Markets Bonds, Mortgage-Backed Securities, the United States Government Agencies, Commercial Mortgage-Backed Securities, Floating Rate Loans, Collateralized Debt Obligations, Asset-Backed Securities, the Non-United States Government Bonds and the United States Treasury Securities. It invests in various sectors, including aerospace, automotive, broadcasting, building, business services, cable television, chemicals, consumer products, consumer services, containers, electronics, entertainment, financial institutions, food and beverages, and gaming and lodging. The Fund's investment advisor is Massachusetts Financial Services Company.

Closing Price
$5.64
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
5.65
Day's Low
5.62
Volume
(Heavy Day)
Volume:
192,296

10-day average volume:
150,897
192,296

UPDATE: ETFMG Alternative Harvest ETF passes $1 billion in assets under management

12:14 pm ET February 6, 2019 (MarketWatch)
Print

The ETFMG Alternative Harvest exchange-traded fund said Wednesday it passed $1 billion in assets under management on Feb. 4, making it the biggest cannabis ETF in the world and the only one listed in the U.S. The ETF is now tracking the performance of a basket of 38 cannabis stocks, including Canada's Cronos Group Inc. (CRON.T) and Canopy Growth Corp. (WEED.T), two players viewed as promising because of large investments from established companies. The fund has gained 37% in the year to date, bolstered by outsize gains by Cronos, up 95%, and Canopy, up 70%. Canada fully legalized cannabis for adult recreational use last October, and a handful of Canadian companies have now listed in the U.S. "This milestone validates investor interest in this emerging industry as well as investor sentiment toward a decades-old drug policy," said Kris Monaco, managing partner of Level ETF Ventures, an index provider to the fund. The Horizons Marijuana Life Sciences ETF , which trades in Canada, was down 5.5% on Wednesday, but has gained 42% in the year to date. The S&P 500 and the Dow Jones Industrial Average have gained about 9% in the year so far.

-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

February 06, 2019 12:14 ET (17:14 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.